Original Research

Published on 03 Feb 2022

Ailanthone Inhibits Proliferation, Migration and Invasion of Osteosarcoma Cells by Downregulating the Serine Biosynthetic Pathway

in Pharmacology of Anti-Cancer Drugs

Yawen Zhang
Runze Gong
Yong Liu
Xipeng Sun
Jinrong Liang
Yan Zhou
Yaling Wang
Wenxi Yu
Yonggang Wang
Lina Tang

Frontiers in Oncology

doi 10.3389/fonc.2022.842406

4,307 views
8 citations

Review

Published on 03 Feb 2022

Local Anesthetic Ropivacaine Exhibits Therapeutic Effects in Cancers

in Pharmacology of Anti-Cancer Drugs

Peng Xu
Shaobo Zhang
Lili Tan
Lei Wang
Zhongwei Yang
Jinbao Li

Frontiers in Oncology

doi 10.3389/fonc.2022.836882

3,538 views
14 citations

Systematic Review

Published on 03 Feb 2022

Prevention of Oxaliplatin-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis

in Pharmacology of Anti-Cancer Drugs

Siyu Peng
Ariel Fangting Ying
Nicholas Jian Hao Chan
Raghav Sundar
Yu Yang Soon
Aishwarya Bandla

Frontiers in Oncology

doi 10.3389/fonc.2022.731223

8,984 views
9 citations

Editorial

Published on 02 Feb 2022

Editorial: Combinatorial Approaches for Cancer Treatment: From Basic to Translational Research

in Pharmacology of Anti-Cancer Drugs

Aniello Cerrato
George Mattheolabakis
Daniela Spano

Frontiers in Oncology

doi 10.3389/fonc.2022.842114

1,886 views
4 citations

Original Research

Published on 02 Feb 2022

Epigenetics-Associated Risk Reduction of Hematologic Neoplasms in a Nationwide Cohort Study: The Chemopreventive and Therapeutic Efficacy of Hydralazine

in Pharmacology of Anti-Cancer Drugs

Bing-Heng Yang
Wei-Zhi Lin
Yu-Ting Chiang
Yeu-Chin Chen
Chi-Hsiang Chung
Wu-Chien Chien
Chia-Yang Shiau

Frontiers in Oncology

doi 10.3389/fonc.2022.809014

2,366 views
2 citations

Original Research

Published on 02 Feb 2022

Safranal Inhibits Angiogenesis via Targeting HIF-1α/VEGF Machinery: In Vitro and Ex Vivo Insights

in Pharmacology of Anti-Cancer Drugs

Ali Abdalla
Chandraprabha Murali
Amr Amin

Frontiers in Oncology

doi 10.3389/fonc.2021.789172

3,873 views
46 citations

Original Research

Published on 01 Feb 2022

Validating RRP12 Expression and Its Prognostic Significance in HCC Based on Data Mining and Bioinformatics Methods

in Pharmacology of Anti-Cancer Drugs

Chao Wei
Ben Wang
Zhong-Huo Chen
Han Xiao
Lei Tang
Jia-Fu Guan
Rong-Fa Yuan
Xin Yu
Zhi-Gang Hu
Hua-Jun Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.812009

3,728 views
8 citations

Case Report

Published on 31 Jan 2022

Life-Threatening Docetaxel Toxicity in a Patient With Reduced-Function CYP3A Variants: A Case Report

in Pharmacology of Anti-Cancer Drugs

Nicholas R. Powell
Tyler Shugg
Reynold C. Ly
Costantine Albany
Milan Radovich
Bryan P. Schneider
Todd C. Skaar

Frontiers in Oncology

doi 10.3389/fonc.2021.809527

4,811 views
11 citations

Original Research

Published on 31 Jan 2022

Lirilumab and Avelumab Enhance Anti-HPV+ Cervical Cancer Activity of Natural Killer Cells via Vav1-Dependent NF-κB Disinhibition

in Pharmacology of Anti-Cancer Drugs

Hongli Liu
Sihui Zhou
Jing Liu
Fuliang Chen
Yuan Zhang
Mengjun Liu
Shengping Min
Hongtao Wang
Xiaojing Wang
Nan Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.747482

2,782 views
8 citations

Mini Review

Published on 31 Jan 2022

Epigenetic Regulation of Ferroptosis-Associated Genes and Its Implication in Cancer Therapy

in Pharmacology of Anti-Cancer Drugs

Yanzi Pei
Yujie Qian
Hao Wang
Li Tan

Frontiers in Oncology

doi 10.3389/fonc.2022.771870

5,734 views
16 citations

Review

Published on 28 Jan 2022

The Role of Graphene Oxide Nanocarriers in Treating Gliomas

in Pharmacology of Anti-Cancer Drugs

Bin Wang
Hanfei Guo
Haiyang Xu
Yong Chen
Gang Zhao
Hongquan Yu

Frontiers in Oncology

doi 10.3389/fonc.2022.736177

3,561 views
16 citations

Original Research

Published on 28 Jan 2022

An Insight on the Pathways Involved in Crizotinib and Sunitinib Induced Hepatotoxicity in HepG2 Cells and Animal Model

in Pharmacology of Anti-Cancer Drugs

Lin Guo
Tingli Tang
Dongmei Fang
Hui Gong
Bikui Zhang
Yueyin Zhou
Leiyi Zhang
Miao Yan

Frontiers in Oncology

doi 10.3389/fonc.2022.749954

2,699 views
3 citations

Editorial

Published on 27 Jan 2022

Editorial: Treatment for Non-Small Cell Lung Cancer in Distinct Patient Populations

in Pharmacology of Anti-Cancer Drugs

Junji Uchino
Torsten Goldmann
Hideharu Kimura

Frontiers in Oncology

doi 10.3389/fonc.2022.838570

1,328 views
4 citations

Case Report

Published on 25 Jan 2022

Vemurafenib Combined With Trametinib Significantly Benefits the Survival of a Patient With Stage IV Pancreatic Ductal Adenocarcinoma With BRAF V600E Mutation: A Case Report

in Pharmacology of Anti-Cancer Drugs

Ziyao Wang
Du He
Chen Chen
Xubao Liu
Nengwen Ke

Frontiers in Oncology

doi 10.3389/fonc.2021.801320

3,033 views
8 citations

Systematic Review

Published on 24 Jan 2022

Efficacy and Safety of Thalidomide As a Pre-Medication of Chemotherapy-Induced Nausea and Vomiting (CINV) Following Highly Emetogenic Chemotherapy (HEC): A Systematic Review and Meta-Analysis

in Pharmacology of Anti-Cancer Drugs

Jiyi Xie
Cong Zhang
Shijun Li
Rong Dai
Mitchell A. Sullivan
Bin Deng
Qiling Xu
Jinglin Wang
Chen Shi
Yu Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.818839

2,811 views
2 citations

Original Research

Published on 21 Jan 2022

Escape From Cisplatin-Induced Senescence of Hypoxic Lung Cancer Cells Can Be Overcome by Hydroxychloroquine

in Pharmacology of Anti-Cancer Drugs

Aleksandra Olszewska
Agata Borkowska
Monika Granica
Justyna Karolczak
Bartosz Zglinicki
Claudine Kieda
Halina Was

Frontiers in Oncology

doi 10.3389/fonc.2021.738385

5,303 views
15 citations

Navigation group

Articles

Ailanthone Inhibits Proliferation, Migration and Invasion of Osteosarcoma Cells by Downregulating the Serine Biosynthetic Pathway

Local Anesthetic Ropivacaine Exhibits Therapeutic Effects in Cancers

Prevention of Oxaliplatin-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis

Editorial: Combinatorial Approaches for Cancer Treatment: From Basic to Translational Research

Epigenetics-Associated Risk Reduction of Hematologic Neoplasms in a Nationwide Cohort Study: The Chemopreventive and Therapeutic Efficacy of Hydralazine

Safranal Inhibits Angiogenesis via Targeting HIF-1α/VEGF Machinery: In Vitro and Ex Vivo Insights

Validating RRP12 Expression and Its Prognostic Significance in HCC Based on Data Mining and Bioinformatics Methods

Life-Threatening Docetaxel Toxicity in a Patient With Reduced-Function CYP3A Variants: A Case Report

Lirilumab and Avelumab Enhance Anti-HPV+ Cervical Cancer Activity of Natural Killer Cells via Vav1-Dependent NF-κB Disinhibition

Epigenetic Regulation of Ferroptosis-Associated Genes and Its Implication in Cancer Therapy

The Role of Graphene Oxide Nanocarriers in Treating Gliomas

An Insight on the Pathways Involved in Crizotinib and Sunitinib Induced Hepatotoxicity in HepG2 Cells and Animal Model

Editorial: Treatment for Non-Small Cell Lung Cancer in Distinct Patient Populations

Vemurafenib Combined With Trametinib Significantly Benefits the Survival of a Patient With Stage IV Pancreatic Ductal Adenocarcinoma With BRAF V600E Mutation: A Case Report

Efficacy and Safety of Thalidomide As a Pre-Medication of Chemotherapy-Induced Nausea and Vomiting (CINV) Following Highly Emetogenic Chemotherapy (HEC): A Systematic Review and Meta-Analysis

Escape From Cisplatin-Induced Senescence of Hypoxic Lung Cancer Cells Can Be Overcome by Hydroxychloroquine